Skull-mounted electrical stimulation system and method for treating patients
First Claim
1. A method of treating patients with epilepsy, movement disorders, or other indications, comprising:
- implanting at least one system control unit (110) in a shallow recess of the mastoid area (143) of the skull (140) of a patient, wherein the at least one unit (110) is capable of controlling the delivery of at least one stimulus to at least one nerve affecting epilepsy, movement disorders, or other indications; and
applying the at least one stimulus to the at least one nerve in order to at least in part alleviate symptoms of epilepsy, movement disorders, or other indications of the patient being treated;
wherein the at least one nerve is selected from at least one of the body, branches, and roots of at least one of the vagus nerves (148), the trigeminal nerves (106), the ophthalmic nerves (118), the maxillary nerves (122), the mandibular nerves (146), the facial nerves (136), the glossopharyngeal nerves (138), and the trigeminal ganglion (102) or ganglia.
2 Assignments
0 Petitions
Accused Products
Abstract
A system and method for applying electrical stimulation or drug infusion to nervous tissue of a patient to treat epilepsy, movement disorders, and other indications uses at least one implantable system control unit (SCU) (110), including an implantable signal/pulse generator (IPG) and one or more electrodes (152, 152′). The IPG is implanted in the mastoid area (143) of the skull (140) and communicates with at least one external appliance (230), such as a Behind-the-Ear (BTE) unit (100). In a preferred embodiment, the system is capable of open- and closed-loop operation. In closed-loop operation, at least one SCU includes a sensor, and the sensed condition is used to adjust stimulation parameters.
320 Citations
18 Claims
-
1. A method of treating patients with epilepsy, movement disorders, or other indications, comprising:
-
implanting at least one system control unit (110) in a shallow recess of the mastoid area (143) of the skull (140) of a patient, wherein the at least one unit (110) is capable of controlling the delivery of at least one stimulus to at least one nerve affecting epilepsy, movement disorders, or other indications; and
applying the at least one stimulus to the at least one nerve in order to at least in part alleviate symptoms of epilepsy, movement disorders, or other indications of the patient being treated;
wherein the at least one nerve is selected from at least one of the body, branches, and roots of at least one of the vagus nerves (148), the trigeminal nerves (106), the ophthalmic nerves (118), the maxillary nerves (122), the mandibular nerves (146), the facial nerves (136), the glossopharyngeal nerves (138), and the trigeminal ganglion (102) or ganglia. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A system for patients with epilepsy, movement disorders, or other indications, comprising:
-
at least one lead (150, 150′
), wherein the at least one lead includes at least one electrode (152, 152′
); and
at least one system control unit (110) having a size and shape suitable for implantation in a recess in the mastoid area (143) of the skull (140), wherein the at least one system control unit (110) comprises;
electronic circuitry (170) that generates stimulation pulses in accordance with prescribed stimulation parameters, which electronic circuitry (170) is operably connected to the at least one electrode (152, 152′
) through which the stimulation pulses may be delivered to issue adjacent to the at least one electrode (152, 152′
);
programmable memory (175) for receiving and storing the prescribed stimulation parameters; and
a power source (180) for providing operating power to the electronic circuitry (170). - View Dependent Claims (8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
-
Specification